AIMD
Ainos, Inc. NASDAQ Listed Jan 8, 2021$1.24
-6.77%
vs $1.33
Mkt Cap $5.3M
52w Low $1.24
0.0% of range
52w High $4.25
50d MA $1.43
200d MA $1.70
P/E (TTM)
-0.5x
EV/EBITDA
—
P/B
0.7x
Debt/Equity
1.4x
ROE
-195.3%
P/FCF
-1.1x
RSI (14)
29.30
ATR (14)
$0.11
Beta
2.32
50d MA
$1.43
200d MA
$1.70
Avg Volume
238.4K
Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.
8880 Rio San Diego Drive · San Diego, CA 92108 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | AMC | — | -0.85 | — | 1.35 | -1.5% | +3.0% | +3.6% | +0.0% | +3.5% | -0.7% | — |
| Nov 13, 2025 | AMC | — | -0.64 | — | 2.58 | -3.1% | -14.3% | +0.0% | +0.9% | -9.4% | -5.4% | — |
| Aug 13, 2025 | AMC | — | -0.99 | — | 3.36 | +0.9% | +13.7% | -9.4% | -3.2% | -0.3% | +3.6% | — |
| May 12, 2025 | AMC | — | -1.05 | — | 2.75 | +1.8% | -1.8% | -1.9% | +2.6% | +0.0% | -2.9% | — |
| Mar 7, 2025 | AMC | — | -1.30 | — | 2.44 | -2.5% | -5.7% | +2.2% | -2.1% | +4.3% | +8.7% | — |
| Nov 6, 2024 | AMC | — | -1.65 | — | 2.53 | -9.1% | -5.5% | +0.4% | +4.2% | -0.4% | -1.2% | — |
| Aug 5, 2024 | AMC | — | -2.45 | — | 2.65 | -1.5% | -6.4% | +4.8% | -0.8% | +1.2% | +8.0% | — |
| May 13, 2024 | AMC | — | -2.85 | — | 5.30 | -0.9% | -1.9% | -1.0% | +1.0% | +0.0% | -3.8% | — |
| Mar 8, 2024 | AMC | — | -1.37 | — | 10.25 | -17.6% | -20.0% | -10.4% | -7.5% | -5.1% | -6.2% | — |
| Feb 7, 2024 | AMC | — | -0.73 | — | 4.70 | +1.1% | -3.0% | +0.4% | +3.5% | -5.1% | +2.2% | — |
| Aug 11, 2023 | AMC | — | -3.00 | — | 17.25 | +0.5% | +5.2% | -4.7% | -9.2% | +1.5% | +5.1% | — |
| May 12, 2023 | AMC | — | -3.25 | — | 18.00 | +2.8% | -1.4% | +4.2% | -5.1% | +0.0% | -0.3% | — |
No analyst ratings available.
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | chiang yao-chungDir | — | Buy | 3,500 | $2.05 | $7K | 11,279 | -7.35% | +2.17% |
| Jun 3, 2026 | chiang yao-chungDir | — | Buy | 2,000 | $2.13 | $4K | 7,779 | +5.13% | -0.52% |
| May 28, 2026 | chiang yao-chungDir | — | Buy | 250 | $2.30 | $575 | 5,779 | +1.29% | +5.13% |
| May 27, 2026 | chiang yao-chungDir | — | Buy | 2,000 | $2.00 | $4K | 5,529 | -2.10% | -12.56% |
| May 26, 2026 | lee ting-chuanDir | — | Sell | 109,988 | $1.90 | $209K | 807,417 | +7.03% | -6.78% |
| May 26, 2026 | Taiwan Carbon Nano Technology Corp10% | — | Sell | 41,000 | $2.36 | $97K | 948,925 | +7.03% | -6.78% |
| May 26, 2026 | TSAI CHUN-JUNGDir | — | Sell | 27,718 | $1.87 | $52K | 658,199 | +7.03% | -6.78% |
| May 22, 2026 | TSAI CHUN-JUNGDir | — | Sell | 1,082 | $1.55 | $2K | 685,917 | +7.03% | -6.78% |
| May 22, 2026 | lee ting-chuanDir | — | Sell | 9,302 | $1.57 | $15K | 917,405 | -18.99% | -2.15% |
| May 21, 2026 | lee ting-chuanDir | — | Sell | 9,000 | $1.56 | $14K | 926,707 | -18.99% | -2.15% |
| May 19, 2026 | chiang yao-chungDir | — | Buy | 2,200 | $1.68 | $4K | 3,529 | +5.33% | +7.03% |
| May 18, 2026 | chiang yao-chungDir | — | Buy | 500 | $1.65 | $825 | 1,329 | +5.33% | +7.03% |
| May 5, 2026 | chiang yao-chungDir | — | Buy | 129 | $1.70 | $219 | 829 | -2.86% | +0.58% |
| Apr 30, 2026 | chiang yao-chungDir | — | Buy | 200 | $1.68 | $336 | 700 | -0.58% | -2.86% |
| Apr 29, 2026 | chiang yao-chungDir | — | Buy | 100 | $1.75 | $175 | 500 | -0.58% | -2.86% |
8-K · 1.01
!! High
Ainos, Inc. -- 8-K 1.01: License Agreement
Sep 28
8-K · 2.02
!! High
Ainos, Inc. -- 8-K 2.02: Earnings Results
Aug 3
8-K · 4.01
!!! Very High
Ainos, Inc. -- 8-K 4.01: Auditor Change / Resignation
Jul 10
8-K · 2.03
! Medium
Ainos, Inc. -- 8-K 2.03: Credit Facility
Ainos, Inc. (AIMD) has established a new credit facility with CTBC Bank, creating a direct financial obligation that will appear on its balance sheet.
Jul 9
8-K · 2.02
!! High
Ainos, Inc. -- 8-K 2.02: Earnings Results
Ainos, Inc. (ACCS, AIMD) released earnings results on May 13, 2026, though specific financial metrics and performance details require reviewing the attached press release exhibit for investment implications.
May 13
8-K
Unknown — 8-K Filing
Ainos' diversified AI Nose platform deployments across multiple industrial sectors position it for significant revenue acceleration in 2026, making this a critical inflection point for investors betting on the company's commercialization trajectory.
Mar 30
Institutional (13F) — Top 9
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Keystone Financial Group | 25,550 | $50K | Added | Jun 2026 |
| 2 | Vanguard Capital Management Llc | 16,024 | $31K | Added | Jun 2026 |
| 3 | Blackrock, Inc. | 3,065 | $6K | New | Jun 2026 |
| 4 | Seneschal Advisors, Llc | 1,800 | $3K | — | Jun 2026 |
| 5 | Steward Partners Investment Advisory, Llc | 1,208 | $2K | — | Mar 2026 |
| 6 | Citigroup Inc | 177 | $343 | Reduced | Jun 2026 |
| 7 | Caitong International Asset Management Co., Ltd | 93 | $180 | New | Jun 2026 |
| 8 | Ubs Group Ag | 2 | $3 | Reduced | Mar 2026 |
| 9 | Cwm, Llc | 1 | $1 | — | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 3
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Fidelity Extended Market Index Fund | 20,997 | $34K | Feb 2026 |
| 2 | Fidelity Series Total Market Index Fund | 2,049 | $5K | May 2026 |
| 3 | Fidelity Nasdaq Composite Index Fund | 396 | $649 | Feb 2026 |
Valuation
Market Cap
$5.3M
Enterprise Value
$15.9M
P/E (TTM)
-0.49x
Forward P/E
—
PEG Ratio
-0.00x
P/B
0.70x
P/S
389.40x
P/FCF
-1.14x
EV/EBITDA
—
Shares Out
4.3M
Financials (TTM)
Revenue
$14K
Net Income
-$14.5M
EBITDA
-$9.0M
Free Cash Flow
-$4.6M
Op Cash Flow
-$4.6M
EPS Basic
$-3.46
EPS Diluted
$-2.52
EPS Forward
—
Gross Margin
—
Op Margin
—
Net Margin
—
Balance Sheet
Total Assets
$20.9M
Total Liab.
$13.3M
Total Equity
$7.6M
Cash
$417K
LT Debt
$11.0M
Book Value/Sh
$1.77
Debt/Equity
1.45x
Current Ratio
1.06
Quick Ratio
0.78
Returns & Growth
ROE
-195.3%
ROA
-70.8%
ROIC
-70.7%
Rev Growth YoY
+498.9%
EPS Growth YoY
-121.8%
Price Returns
2W
-2.9%
1M
-5.7%
3M
-25.7%
6M
-4.3%
12M
-61.8%
Technicals
52W High
$4.25
52W Low
$1.24
50d MA
$1.43
200d MA
$1.70
RSI (14)
29.30
ATR (14)
$0.11
Beta
2.32
Avg Volume
238K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
—
High
—
Low
—
Median
—
Data updated apr 24, 2026 4:51pm
· Source: financialmodelingprep.com